These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9420652)

  • 1. Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death.
    Rector TS; Tschumperlin LK; Kubo SH; Bank AJ; Francis GS; McDonald KM; Keeler CA; Silver MA
    J Card Fail; 1995 Jun; 1(3):201-6. PubMed ID: 9420652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
    Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences of heart failure patients in daily clinical practice: quality of life or longevity?
    Kraai IH; Vermeulen KM; Luttik ML; Hoekstra T; Jaarsma T; Hillege HL
    Eur J Heart Fail; 2013 Oct; 15(10):1113-21. PubMed ID: 23650130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial.
    Ambrosy AP; Khan H; Udelson JE; Mentz RJ; Chioncel O; Greene SJ; Vaduganathan M; Subacuis HP; Konstam MA; Swedberg K; Zannad F; Maggioni AP; Gheorghiade M; Butler J
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27140204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period.
    Papadopoulou EF; Mavrogeni SI; Dritsas A; Cokkinos DV
    Hellenic J Cardiol; 2009; 50(4):269-74. PubMed ID: 19622496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Reported Health-Related Quality of Life Is a Predictor of Outcomes in Ambulatory Heart Failure Patients Treated With Left Ventricular Assist Device Compared With Medical Management: Results From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management).
    Stehlik J; Estep JD; Selzman CH; Rogers JG; Spertus JA; Shah KB; Chuang J; Farrar DJ; Starling RC;
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parent reports of health-related quality of life and heart failure severity score independently predict outcome in children with dilated cardiomyopathy.
    den Boer SL; Baart SJ; van der Meulen MH; van Iperen GG; Backx AP; Ten Harkel AD; Rammeloo LA; du Marchie Sarvaas GJ; Tanke RB; Helbing WA; Utens EM; Dalinghaus M
    Cardiol Young; 2017 Aug; 27(6):1194-1202. PubMed ID: 28290258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for quality of life or survival expressed by patients with heart failure.
    Lewis EF; Johnson PA; Johnson W; Collins C; Griffin L; Stevenson LW
    J Heart Lung Transplant; 2001 Sep; 20(9):1016-24. PubMed ID: 11557198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The last six months of life for patients with congestive heart failure.
    Levenson JW; McCarthy EP; Lynn J; Davis RB; Phillips RS
    J Am Geriatr Soc; 2000 May; 48(S1):S101-9. PubMed ID: 10809463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay.
    Krahn AD; Snell L; Yee R; Finan J; Skanes AC; Klein GJ
    Can J Cardiol; 2002 Apr; 18(4):380-7. PubMed ID: 11992131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years.
    Packer M; Pitt B; Rouleau JL; Swedberg K; DeMets DL; Fisher L
    JACC Heart Fail; 2017 Jun; 5(6):399-407. PubMed ID: 28501522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Euro Cardio-QoL Project. An international study to develop a core heart disease health-related quality of life questionnaire, the HeartQoL.
    Oldridge N; Saner H; McGee HM;
    Eur J Cardiovasc Prev Rehabil; 2005 Apr; 12(2):87-94. PubMed ID: 15785293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of the Minnesota Living With Heart Failure Quality of Life Questionnaire in Spain].
    Parajón T; Lupón J; González B; Urrutia A; Altimir S; Coll R; Prats M; Valle V
    Rev Esp Cardiol; 2004 Feb; 57(2):155-60. PubMed ID: 14967111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure treatments: issues of safety versus issues of quality of life.
    Feenstra J; Lubsen J; Grobbee DE; Stricker BH
    Drug Saf; 1999 Jan; 20(1):1-7. PubMed ID: 9935272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illness perception, self-care behaviour and quality of life of heart failure patients: a longitudinal questionnaire survey.
    Goodman H; Firouzi A; Banya W; Lau-Walker M; Cowie MR
    Int J Nurs Stud; 2013 Jul; 50(7):945-53. PubMed ID: 23211796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group.
    Rector TS; Cohn JN
    Am Heart J; 1992 Oct; 124(4):1017-25. PubMed ID: 1529875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure.
    Chin MH; Goldman L
    Med Care; 1998 Jul; 36(7):1033-46. PubMed ID: 9674621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan.
    Moe GW; Rouleau JL; Charbonneau L; Proulx G; Arnold JM; Hall C; de Champlain J; Barr A; Sirois P; Packer M
    Am Heart J; 2000 Apr; 139(4):587-95. PubMed ID: 10740139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile of patients with heart failure can predict rehospitalization and quality of life.
    Di Mauro M; Petroni R; Clemente D; Foschi M; Tancredi F; Camponetti V; Gallina S; Calafiore AM; Penco M; Romano S
    J Cardiovasc Med (Hagerstown); 2018 Mar; 19(3):98-104. PubMed ID: 29342024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.